Life-Threatening Aorto-Atrial Erosion Following Transcatheter Ostium Secundum Atrial Septal Defect Closure: A

Silvia Deaconu1,2, Dan Deleanu1, Mircea Ioan Alexandru Bistriceanu3

  • 1Monza-Ares Hospital, 021967 Bucharest, Romania.

Insights

Cardiac erosion after atrial septal defect (ASD) closure is rare but serious. This review of 40 cases highlights aortic erosion, often linked to device issues and anatomical factors, requiring surgical repair.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Cardiac erosion is a rare, life-threatening complication following transcatheter closure of secundum atrial septal defects (ASD).
  • Existing evidence is limited to case reports and small series, necessitating further comprehensive review.

Purpose of the Study:

  • To synthesize available evidence on aortic and aorto-atrial erosion after transcatheter secundum ASD closure.
  • To identify clinical, anatomical, procedural, and outcome characteristics of this complication.

Main Methods:

  • A systematic case-based review of literature (PubMed, Scopus, Web of Science, CENTRAL) up to January 2026.
  • Inclusion of adult cases with confirmed aortic or aorto-atrial erosion post-ASD closure.
  • Descriptive synthesis of clinical, anatomical, procedural, imaging, management, and outcome data.

Main Results:

  • Forty cases were identified, with a median age of 39.5 years and 27% female.
  • Chest pain was the most common symptom; median time to erosion was 81 days.
  • Deficient retro-aortic rim (22 cases) and device oversizing (17 cases) were frequent findings. All erosions involved the aorta, predominantly aorta-right atrial (21 cases) or aorta-left atrial (14 cases).

Conclusions:

  • Aortic and aorto-atrial erosion is an uncommon yet severe complication of transcatheter ASD closure.
  • Recurrent factors include female sex, deficient retro-aortic rim, device oversizing, and mild aortic root dilation.
  • Early recognition necessitates careful anatomical assessment, multimodality imaging, and ongoing patient follow-up.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations: